2m 2m 2m 2m 2m 2m 2m
ROYAL PHARM -A (RPRX)
NASDAQ
$58.08+$0.92 (+1.61%)
Price as of Oct 02, 2026 7:30 PM EDT- $25.5BMarket Cap
- 61.54%1-Year Change
- BiotechnologyIndustry
ROYAL PHARM -A (RPRX)
$58.08+$0.92 (+1.61%)
RPRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $57.16 | ||
Change | -$0.47 (-0.82%) | ||
Open | $57.63 | ||
High | $57.91 | ||
Low | $56.96 | ||
Previous Close | $57.63 | ||
Volume | 2,229,485 | ||
30-Day Average Volume | 3,259,636 | ||
1-Week Change | -1.80% | ||
1-Month Change | -9.43% | ||
1-Year Change | 61.54% | ||
3-Year Change | 130.17% | ||
5-Year Change | 77.32% | ||
Fundamentals | |||
Shares Outstanding | 443.2M | ||
Total Assets | $19.8B | ||
Market Cap | $25.5B | ||
Enterprise Value | $33.7B | ||
Period: QTR TTM FY | |||
Revenue | $638.0M | ||
Net Income | $17.9M | ||
Free Cash Flow | $728.5M | ||
EBIT | $17.9M | ||
EBITDA | $19.2M | ||
Net Working Capital | $1.1B | ||
EPS | $0.04 | ||
Enterprise Value/EBITDA | 1,757 | ||
Enterprise Value/Revenue | 53 | ||
P/B | 3 | ||
P/E | 1,441 | ||
PEG | -15 | ||
Price/Free Cash Flow | 35 | ||
Price/Operating Cash Flow | 35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.64% | ||
Trailing Annual Dividend Yield | 1.62% | ||
Ex-Dividend Date | 08/14/2026 | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 10/15/2010 | ||
Earnings & Revenue
Annual Dividend Yield